Vivos Therapeutics, Inc.
VVOS
$0.53
-$0.04-7.15%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -9.91% | -67.59% | -51.09% | -36.23% | -10.30% |
| Total Receivables | 146.38% | 267.67% | 370.04% | 313.42% | 36.76% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 71.85% | -1.15% | -10.88% | 25.45% | 15.16% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 33.60% | -41.34% | -21.80% | -14.29% | -0.11% |
|
|
|||||
| Total Current Assets | 33.60% | -41.34% | -21.80% | -14.29% | -0.11% |
| Net Property, Plant & Equipment | 77.48% | 82.43% | 102.99% | 87.06% | -8.09% |
| Long-term Investments | 201.51% | 201.51% | 197.22% | 197.22% | 0.00% |
| Goodwill | 201.51% | 201.51% | 197.22% | 197.22% | 0.00% |
| Total Other Intangibles | 972.35% | 889.00% | 467.10% | 463.29% | -12.25% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 18.14% | 5.56% | -23.55% | -7.61% | -30.19% |
| Total Assets | 121.97% | 64.56% | 67.09% | 64.33% | -4.42% |
|
|
|||||
| Total Accounts Payable | 65.51% | 52.91% | 95.63% | -13.07% | -51.74% |
| Total Accrued Expenses | 242.66% | 168.04% | 30.57% | 5.35% | -27.66% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1,634.26% | 1,803.56% | 132.58% | 78.93% | -3.31% |
| Total Finance Division Other Current Liabilities | 38.99% | 13.69% | 0.79% | -23.18% | -52.56% |
| Total Other Current Liabilities | 38.99% | 13.69% | 0.79% | -23.18% | -52.56% |
| Total Current Liabilities | 281.56% | 263.12% | 45.08% | -3.27% | -41.75% |
|
|
|||||
| Total Current Liabilities | 281.56% | 263.12% | 45.08% | -3.27% | -41.75% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 302.47% | 281.93% | 158.29% | 130.86% | -33.38% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 238.49% | 219.21% | 207.94% | 174.11% | -29.15% |
| Total Liabilities | 282.69% | 264.28% | 200.86% | 125.91% | -38.74% |
|
|
|||||
| Common Stock & APIC | 17.29% | 10.46% | 10.98% | 11.95% | 15.46% |
| Retained Earnings | -23.13% | -20.32% | -16.87% | -14.50% | -11.61% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -125.82% | -118.73% | -66.97% | -27.79% | 657.22% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -125.82% | -118.73% | -66.97% | -27.79% | 657.22% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -128.75% | -119.49% | -66.97% | -27.79% | 657.22% |
|
|
|||||